The world faces economic headwinds. According to the Economist, Europe’s economy only grew at 4% this decade as compared with 8% of the United States and is struggling with a triple shock of the energy crisis, surging Chinese imports, and the threat of tariffs from the United States.
The medical device market is expected to grow by almost $178 billion from 2023 to 2027 according to Technavio. Moreover, a Fortune Business Insights Analysis estimates the market to reach $799 billion by 2030. With such significant growth, manufacturing and supply chains must scale and mitigate risk to ensure supplies to customers and patients.
As Mexico ushers in its first female president, Claudia Sheinbaum Pardo, and reaffirms its commitment to the "fourth transformation," Lisa Anderson, MBA, CSCP, CLTD, President of LMA Consulting Group Inc., shares her insights on how this political shift is expected to enhance nearshoring opportunities for U.S. manufacturers.
The risk of China has increased dramatically over the years. Early on, executives were concerned about intellectual property theft. Although that is still a concern, there are much bigger issues.
If you are dependent on any region, non-friendly country, customer, supplier, material, or anything noteworthy to your success, you must diversify. Although this concept has always been true, the pandemic highlighted the critical importance. Some companies simply lost their source of supply overnight and have not recovered if not diversified.
Manufacturers should work to reduce materials, energy consumption, and inefficiencies to improve their carbon footprint and achieve the triple bottom line.
There are around 3 million industrial robots in use worldwide, and the market is expected to grow to $45 billion by 2028. At a minimum, robots can perform routine tasks with consistent quality. At a maximum, robots will be a strategic advantage to your business. It is no wonder clients are implementing them at a fast pace and investing widely.
Lisa Anderson addresses the significant challenges posed by recent quality issues at Boeing and their widespread effects on the aerospace and related supply chains. Drawing from her in-depth industry experience, Ms. Anderson offers vital strategies for companies to navigate these disruptions effectively.